Publications by authors named "U Muenster"

Claim this Profile
D
Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 1: in vitro modeling of vericiguat.
Paul Vrenken, Maria Vertzoni, Sebastian Frechen, Juri Solodenko, Michaela Meyer, Uwe Muenster

Eur J Pharm Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: in vivo pharmacokinetic modeling of vericiguat.
Paul Vrenken, Maria Vertzoni, Sebastian Frechen, Juri Solodenko, Michaela Meyer, Uwe Muenster

Eur J Pharm Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Contents of Lower intestine in the 65-74 Years of Age Range Could Impact the Performance of Safe and Efficacious Modified Release Products.
Maria Vertzoni, Sarah Sulaiman, Konstantinos Goumas, Elisabeth Kersten, Johanna Anlahr, Uwe Muenster

J Pharm Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering large porous microparticles with tailored porosity and sustained drug release behavior for inhalation.
Xiaofei Zhang, Lu Qin, Jian Su, Ying Sun, Lan Zhang, Uwe Muenster

Eur J Pharm Biopharm· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro-in vivo correlation of inhalable budesonide-loaded large porous particles for sustained treatment regimen of asthma.
Jiaqi Li, Huangliang Zheng, Lu Qin, En-Yu Xu, Linglong Yang, Uwe Muenster

Acta Biomater· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis